Trelegy Ellipta

Active Ingredient: fluticasone furoate, umeclidinium (as bromide) and vilanterol (trifenatate)

Consumer Medicine Information

The Consumer Medicine Information is a leaflet written for people who have been prescribed this product. This information is intended for use in Australia only and does not replace advice from a healthcare professional. You should discuss the CMI with your healthcare professional if you have any questions or concerns.

Download Trelegy Ellipta CMI (PDF)

Product Information

The Product Information is intended to assist healthcare professionals make decisions about treatment options and provide advice on the appropriate use of a medicine to patients. This information only applies to GSK products available in Australia.

Download Trelegy Ellipta PI (PDF)